Search results
Author(s):
Nicole Ebner
,
Stephan Von Haehling
Added:
3 years ago
Iron is an essential trace element that is present in a number of molecular systems, and it is increasingly recognised as an important cofactor for a variety of cell systems.1 It has been acknowledged that iron plays an important role in oxygen transport, as well as in cell growth and proliferation. In recent years, more insight has been gained into iron physiology and the regulation of cellular…
View more
Amina Rakisheva
Job title: Consultant in Cardiology Department
Author
Author(s):
Aniket S Rali
,
Siva Taduru
,
Lena E Tran
,
et al
Added:
1 year ago
Author(s):
Martin R Cowie
Added:
9 months ago
HFA 23 - In this short interview, Prof Martin Cowie (Clinical Vice-President AstraZeneca R&D & Honorary Consultant Cardiologist, Guy’s & St Thomas’ NHS Foundation Trust, London, UK) joins us to discuss the findings from a prespecified analysis of the DELIVER trial which covered the characteristics, outcomes and effects of dapagliflozin according to the duration of heart failure.
DELIVER was…
View more
Author(s):
Jelena Celutkiene
,
Mindaugas Balčiūnas
,
Denis Kablučko
,
et al
Added:
3 years ago
Heart failure (HF) and chronic obstructive pulmonary disease (COPD) comorbidity poses substantial diagnostic and therapeutic challenges in acute care settings. Outcomes of this comorbidity are worse than in either disease alone.1,2 A hospital diagnosis of COPD is an independent predictor of all-cause and non-cardiovascular mortality in HF patients,3–5 associated with decrease in use of evidence…
View more
Author(s):
Cristiana Vitale
,
Ilaria Spoletini
,
Giuseppe Rosano
Added:
3 years ago
Because of the ageing population in industrialised countries, the prevalence of cardiovascular disease has dramatically increased.1 In particular, heart failure (HF) has become a major public health problem and the leading cause of morbidity, hospitalisation and mortality in older people.2,3
Patients with HF, especially the oldest, are often characterised by a “vulnerability status” due to the…
View more
Author(s):
Eilidh Hill
,
Jackie Taylor
Added:
3 years ago
In developed countries, it is estimated that 1–2 % of the adult population has heart failure (HF), with the prevalence increasing to more than 10 % in those aged >70 years.1 Despite advances in therapies for heart failure with reduced ejection fraction (HFrEF), it remains a condition associated with significant morbidity and mortality, punctuated by episodes of unplanned hospitalisation.2
HF…
View more
Author(s):
Kanako Teramoto
,
Tiew-Hwa Katherine Teng
,
Chanchal Chandramouli
,
et al
Added:
1 year ago
Author(s):
Ferdinando Iellamo
,
Barbara Sposato
,
Maurizio Volterrani
Added:
3 years ago
The contemporary treatment planning of heart failure (HF) is based on guideline-directed medical therapy recommendations. The management of HF patients at home has become more driven by symptoms and nurse evaluation, as well as by simple monitoring techniques, such as daily weight measurements, to adjust diuretictherapy.
Noninvasive Monitoring
Nowadays, technological developments have made it…
View more
Author(s):
David R Thompson
,
Chantal F Ski
,
Alexander M Clark
,
et al
Added:
1 year ago